PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical - PowerPoint PPT Presentation

Jan 03, 2024 •143 likes •334 views

PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical Forum General Director, CV Protek Adam Smith Conferences,16th May 20, 2010 IMPORTANT NOTICE (Disclaimer) This presentation has been prepared by OJSC Protek (the

PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical Forum General Director, CV Protek Adam Smith Conferences,16th May 20, 2010

Recommend

WHERE IS INDIAN PHARMA HEADED? Motilal Oswal 2017 Conference Nilesh Gupta Managing Director

WHERE IS INDIAN PHARMA HEADED? Motilal Oswal 2017 Conference Nilesh Gupta Managing Director Lupin Ltd. September 2017 IS THE INDIAN PHARMA DREAM RUN OVER? Pharma Company Growth and Returns Indian Pharma Company Growth Indian Pharma

592 views • 45 slides

About United Pharma Canada United Pharma is a modern Canadian manufacturing company , specialized

About United Pharma Canada United Pharma is a modern Canadian manufacturing company , specialized in manufacturing Pharmaceutical, Nutraceuticals andCosmeceuticalproducts that adopt new technology . Currently , the aim of United Pharma is to

433 views • 41 slides

Pharma Resources Come in and get to know Pharma Resources. We appreciate your interest. Welcome

Pharma Resources Come in and get to know Pharma Resources. We appreciate your interest. Welcome to Pharma Resources For over 20 years we assist and support our customers in the healthcare industry in bringing pharmaceuticals and medical devices

1.04k views • 18 slides

PENTA-ID and Pharma collaborations Enpr-EMA 2013 PENTA-ID and Pharma collaboration

PENTA-ID and Pharma collaborations Enpr-EMA 2013 PENTA-ID and Pharma collaboration Complex and wide ranging interactions Working with SME and large Pharma Phase I, II, III, IV Many good examples of collaborative

286 views • 12 slides

Pharma Strategies for a New Reimbursement Environment New York Pharma Forum March 26, 2012

Pharma Strategies for a New Reimbursement Environment New York Pharma Forum March 26, 2012 Roger Longman roger.longman@realendpoints.com 1 Pharma business model under threat as R&D less likely to drive value If cost of extracting coal

424 views • 23 slides

Vistin Pharma Corporate Presentation October 2016 Content Introduction to Vistin Pharma

Vistin Pharma Corporate Presentation October 2016 Content Introduction to Vistin Pharma Operational and financial update Summary & outlook Appendix Snapshot Vistin at a glance Summary Presence in c.40 countries Established in June

785 views • 22 slides

Synact Pharma AB A new medicine to treat inflammatory diseases Jeppe vlesen, MBA Thomas

Synact Pharma AB A new medicine to treat inflammatory diseases Jeppe vlesen, MBA Thomas Jonassen, MD CEO CSO Sedermera Dagen Copenhagen, March 13, 2018 SYNACT PHARMA OVERVIEW Synact Pharma AB listed at Aktietorget in July 2016

632 views • 15 slides

Attributes of Pharma Biotech Patenting a European Perspective a European Perspective Szeged May

Gedeon Richter Pharma GmbH, BioIP Department Attributes of Pharma Biotech Patenting a European Perspective a European Perspective Szeged May 11, 2012 Walter Hinderer 1 Attributes of Pharma Biotech Patenting > Agenda Agenda [Slide No.]:

259 views • 24 slides

Aurobindo Pharma Limited Q4FY20 & FY20 Earnings Presentation 3 rd June 2020 Aurobindo Pharma

Aurobindo Pharma Limited Q4FY20 & FY20 Earnings Presentation 3 rd June 2020 Aurobindo Pharma Limited Earnings Presentation 2 Disclaimer This presentation is provided for informational purposes only and does not constitute or form part of

645 views • 20 slides

Springer for R&D Pharma Springer for R&D Pharma Springer for R&D

Springer for R&D Pharma Springer for R&D Pharma Springer for R&D rd.springer.com Immediate Access to Quality STM Research Thousands of eBooks, Journals and eReference Works on one platform Customized collections for

250 views • 12 slides

New York Pharma Forum NIF Ventures JUNE 23, 2005 Goro Takeda New York Pharma Forum June 23,

New York Pharma Forum NIF Ventures JUNE 23, 2005 Goro Takeda New York Pharma Forum June 23, 2005 CONFIDENTIAL NIF Ventures At a Glance Global VC Firm with Over 20 Years of Operational History Founded in 1982 $1.4B under management

516 views • 37 slides

Airport Infrastructure Development A Cargo Pharma SCL Indonesia 2018 Shangri La, Jakarta PT.

Airport Infrastructure Development A Cargo Pharma SCL Indonesia 2018 Shangri La, Jakarta PT. Angkasa Pura II Group [1] Facts & Figures Pharma Industry [2] IATA Pharma Standardization [3] Infrastructure Development at Airport [3] Index

496 views • 31 slides

Pharma Innovation a Pharma Inno tion at K Korea - Business Oppor usiness Opportunities in K

Pharma Innovation a Pharma Inno tion at K Korea - Business Oppor usiness Opportunities in K unities in Korea a - October 23, 2014 Dahee JEONG Director of Bio-Medical Industry, Investment Promotion Department Invest Korea , KOTRA

1.03k views • 55 slides

Aurobindo Pharma Limited Q1FY21 Earnings Presentation 12 th August 2020 Aurobindo Pharma Limited

Aurobindo Pharma Limited Q1FY21 Earnings Presentation 12 th August 2020 Aurobindo Pharma Limited Earnings Presentation 2 Disclaimer This presentation is provided for informational purposes only and does not constitute or form part of any

517 views • 17 slides

Aurobindo Pharma Limited Q3FY20 Earnings Presentation 6 th February 2020 Aurobindo Pharma Limited

Aurobindo Pharma Limited Q3FY20 Earnings Presentation 6 th February 2020 Aurobindo Pharma Limited Earnings Presentation 2 Disclaimer This presentation is provided for informational purposes only and does not constitute or form part of any

544 views • 16 slides

Presentation of the label Certicold PHARMA Sommaire 1. Pharmaceutical context 2. The

Presentation of the label Certicold PHARMA Sommaire 1. Pharmaceutical context 2. The Certicold Pharma Solution 3. The labelled products 4. Why choose Certicold Pharma? 5. Mode of labelling 6. Who is issuing the label? 1

686 views • 24 slides

RESULTS 2015 1 Operating environment The Bank of Russia continued the process of active

RESULTS 2015 1 Operating environment The Bank of Russia continued the process of active recovery of In this regard, there is an outflow of customer accounts from small the banking system in 2015. As a result there were revoked the banks to

353 views • 18 slides

Russia in the Global Economy: Challenges ahead Bikas Joshi Resident Representative

Russia in the Global Economy: Challenges ahead Bikas Joshi Resident Representative International Monetary Fund Moscow, Russia October 15, 2014 The WEO forecast has been revised down, New mediocre mainly on account of emerging

243 views • 20 slides

Investors and Analysts Presentation: 1H 2010 Financial Results Moscow, 23 September 2010

Investors and Analysts Presentation: 1H 2010 Financial Results Moscow, 23 September 2010 Disclaimer This presentation contains "forward-looking statements" which include all statements other than statements of historical fact. Such

132 views • 11 slides

INTER RAO Export, LLC: Engineering and supply of power equipment 2019 Inter RAO Group

INTER RAO Export, LLC: Engineering and supply of power equipment 2019 Inter RAO Group International R&D and Energy Power Generation Retail Power Supply Power Grids Engineering Power Trading Efficiency Russian strategic

231 views • 6 slides

PROTEK GROUP A LEADER IN RUSSIAN PHARMACEUTICAL MARKET Moscow 2010 www.protek-group.ru

PROTEK GROUP A LEADER IN RUSSIAN PHARMACEUTICAL MARKET Moscow 2010 www.protek-group.ru IMPORTANT NOTICE (Disclaimer) Matters discussed in this presentation may constitute forward-looking statements. Forward-looking statements include

403 views • 19 slides

Temporal dynamics of volatility spillover: The case of energy markets Roy Endr Dahl Atle

Temporal dynamics of volatility spillover: The case of energy markets Roy Endr Dahl Atle Oglend University of Stavanger University of Stavanger Norway - 4036 Stavanger Norway - 4036 Stavanger roy.e.dahl@uis.no atle.oglend@uis.no Muhammad

696 views • 19 slides

PLAN FILLED-IN INFORMATION FROM BANKCHECKS BASED ON PRIOR Automatic Bankcheck Processing

AUTOMATIC EXTRACTION OF PLAN FILLED-IN INFORMATION FROM BANKCHECKS BASED ON PRIOR Automatic Bankcheck Processing KNOWLEDGE ABOUT LAYOUT Characteristics of Checks STRUCTURE Bankcheck Modeling Background and Printed Info

320 views • 4 slides

(Micro) Insurance against Natural Catastrophes for MSMEs - A toolkit for public and private

(Micro) Insurance against Natural Catastrophes for MSMEs - A toolkit for public and private entities - Antonis Malagardis, GIZ RFPI Page 1 Outline 1. Microinsurance works! 2. The response of MI to Typhoon Haiyan 3. SMEs and insurance 4. A

392 views • 20 slides

More recommend

Explore More Topics

Stay informed with curated content and fresh updates.

animals pets art culture automotive transportation business finance computer internet construction architecture education-career electronics communication

PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical - PowerPoint PPT Presentation

PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical Forum General Director, CV Protek Adam Smith Conferences,16th May 20, 2010 IMPORTANT NOTICE (Disclaimer) This presentation has been prepared by OJSC Protek (the

WHERE IS INDIAN PHARMA HEADED? Motilal Oswal 2017 Conference Nilesh Gupta Managing Director

About United Pharma Canada United Pharma is a modern Canadian manufacturing company , specialized

Pharma Resources Come in and get to know Pharma Resources. We appreciate your interest. Welcome

PENTA-ID and Pharma collaborations Enpr-EMA 2013 PENTA-ID and Pharma collaboration

Pharma Strategies for a New Reimbursement Environment New York Pharma Forum March 26, 2012

Vistin Pharma Corporate Presentation October 2016 Content Introduction to Vistin Pharma

Synact Pharma AB A new medicine to treat inflammatory diseases Jeppe vlesen, MBA Thomas

Attributes of Pharma Biotech Patenting a European Perspective a European Perspective Szeged May

Aurobindo Pharma Limited Q4FY20 & FY20 Earnings Presentation 3 rd June 2020 Aurobindo Pharma

Springer for R&D Pharma Springer for R&D Pharma Springer for R&D

New York Pharma Forum NIF Ventures JUNE 23, 2005 Goro Takeda New York Pharma Forum June 23,

Airport Infrastructure Development A Cargo Pharma SCL Indonesia 2018 Shangri La, Jakarta PT.

Pharma Innovation a Pharma Inno tion at K Korea - Business Oppor usiness Opportunities in K

Aurobindo Pharma Limited Q1FY21 Earnings Presentation 12 th August 2020 Aurobindo Pharma Limited

Aurobindo Pharma Limited Q3FY20 Earnings Presentation 6 th February 2020 Aurobindo Pharma Limited

Presentation of the label Certicold PHARMA Sommaire 1. Pharmaceutical context 2. The

RESULTS 2015 1 Operating environment The Bank of Russia continued the process of active

Russia in the Global Economy: Challenges ahead Bikas Joshi Resident Representative

Investors and Analysts Presentation: 1H 2010 Financial Results Moscow, 23 September 2010

INTER RAO Export, LLC: Engineering and supply of power equipment 2019 Inter RAO Group

PROTEK GROUP A LEADER IN RUSSIAN PHARMACEUTICAL MARKET Moscow 2010 www.protek-group.ru

Temporal dynamics of volatility spillover: The case of energy markets Roy Endr Dahl Atle

PLAN FILLED-IN INFORMATION FROM BANKCHECKS BASED ON PRIOR Automatic Bankcheck Processing

(Micro) Insurance against Natural Catastrophes for MSMEs - A toolkit for public and private

Explore More Topics

Sambuz

Useful Links

Newsletter

Mail Us

PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical - PowerPoint PPT Presentation

PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical Forum General Director, CV Protek Adam Smith Conferences,16th May 20, 2010 IMPORTANT NOTICE (Disclaimer) This presentation has been prepared by OJSC Protek (the

WHERE IS INDIAN PHARMA HEADED? Motilal Oswal 2017 Conference Nilesh Gupta Managing Director

About United Pharma Canada United Pharma is a modern Canadian manufacturing company , specialized

Pharma Resources Come in and get to know Pharma Resources. We appreciate your interest. Welcome

PENTA-ID and Pharma collaborations Enpr-EMA 2013 PENTA-ID and Pharma collaboration

Pharma Strategies for a New Reimbursement Environment New York Pharma Forum March 26, 2012

Vistin Pharma Corporate Presentation October 2016 Content Introduction to Vistin Pharma

Synact Pharma AB A new medicine to treat inflammatory diseases Jeppe vlesen, MBA Thomas

Attributes of Pharma Biotech Patenting a European Perspective a European Perspective Szeged May

Aurobindo Pharma Limited Q4FY20 &amp; FY20 Earnings Presentation 3 rd June 2020 Aurobindo Pharma

Springer for R&amp;D Pharma Springer for R&amp;D Pharma Springer for R&amp;D

New York Pharma Forum NIF Ventures JUNE 23, 2005 Goro Takeda New York Pharma Forum June 23,

Airport Infrastructure Development A Cargo Pharma SCL Indonesia 2018 Shangri La, Jakarta PT.

Pharma Innovation a Pharma Inno tion at K Korea - Business Oppor usiness Opportunities in K

Aurobindo Pharma Limited Q1FY21 Earnings Presentation 12 th August 2020 Aurobindo Pharma Limited

Aurobindo Pharma Limited Q3FY20 Earnings Presentation 6 th February 2020 Aurobindo Pharma Limited

Presentation of the label Certicold PHARMA Sommaire 1. Pharmaceutical context 2. The

RESULTS 2015 1 Operating environment The Bank of Russia continued the process of active

Russia in the Global Economy: Challenges ahead Bikas Joshi Resident Representative

Investors and Analysts Presentation: 1H 2010 Financial Results Moscow, 23 September 2010

INTER RAO Export, LLC: Engineering and supply of power equipment 2019 Inter RAO Group

PROTEK GROUP A LEADER IN RUSSIAN PHARMACEUTICAL MARKET Moscow 2010 www.protek-group.ru

Temporal dynamics of volatility spillover: The case of energy markets Roy Endr Dahl Atle

PLAN FILLED-IN INFORMATION FROM BANKCHECKS BASED ON PRIOR Automatic Bankcheck Processing

(Micro) Insurance against Natural Catastrophes for MSMEs - A toolkit for public and private

Explore More Topics

Sambuz

Useful Links

Newsletter

Mail Us

Aurobindo Pharma Limited Q4FY20 & FY20 Earnings Presentation 3 rd June 2020 Aurobindo Pharma

Springer for R&D Pharma Springer for R&D Pharma Springer for R&D